All Research on Pharmaceutical Manufacturers in Europe

Insight

Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Pfizer Inc: Re-entry to the OTC healthcare market

Pfizer exited the OTC healthcare market in 2006 with the sale of its Consumer Healthcare division. In 2009, Pfizer re-entered the market. This case study will examine Pfizer's growth, disposal of the OTC division, and the subsequent market re-entry.

Published By MarketLine
$495
Buy

View all Insight >>

Market Data

Databook
Databook

Company Financials: Shire plc

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
$75
Buy

Profiles

Company Profile
Company Profile

Novartis AG

Novartis (or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 150 countries. It is headquartered in Basel, Switzerland, and employed 135,696 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Industry Profile
Industry Profile

Germany - Generics

Essential resource for top-line data and analysis covering the Germany generics market. This industry profile includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Published By MarketLine
$350
Buy
Industry Profile
Industry Profile

Spain - Generics

Essential resource for top-line data and analysis covering the Spain generics market. This industry profile includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Published By MarketLine
$350
Buy

View all Profiles >>

No help is available.